Experimental Obesity Drug Could Treat Diabetes

Posted on November 24, 2009 in Diabetes Treatment, Latest News

‘Fastostatin’ is a new drug to treat obesity. A team of International researchers at Texas and Japan, were experimenting with this medicine with mice. The mice were found to lose weight along with lowered levels of cholesterol. They have identified a small molecule in the medicine. This molecule can alter the genetic code in the body which is responsible in turning the food into fat molecules. This feature makes it ideal to treat pre-diabetes arising due to over-weight and high cholesterol symptoms.

‘Fatostatin’ helps in checking the further increase in the body weight. It controls on fat accumulation and increase of blood sugar levels in body. All the success have been found with animals only. Implementation over humans is yet to be found. But scientists believe that this drug can also help in controlling the insulin levels in humans. After a medication for a month, the mice showed fat reduction by 12% and 70% drop in their blood sugar levels.

There are some element binding proteins in our body. These proteins have specific areas on them, which they use to bind with their respective DNA-binding sites. These proteins make certain modifications in the synthesis of the specific proteins which result in fat formation in the body. This new medicine interferes with these element binding proteins. Thus, our body stops all the negative reactions towards food by converting food directly into energy and waste but no fat production.

Majority of experiments successful on animals showed low success rate on humans. But many pharmaceutical consultants think that this new drug will have tremendous results in curing obesity-associated conditions like – Cholesterol, Heart disease or Diabetes. Scientists believe that ‘Fatostatin’ goes back to the fat synthesis starting point and acts over there. But the real result is yet to be proven. The drug will be tested on humans the soonest.

Comments

Leave a Reply